Home > > > > > Report Detail

Global Multiple Sclerosis Drugs Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 10-Jul-2019
No. of pages: 94
Inquire Before Buying

Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells. This damage blocks messages between brain and the body and leads to the symptoms of MS. Some of the major symptoms of MS include thinking and memory problems, visual disturbances, problem in coordination and balancing of the body and muscle weakness.

MS affects women more than men. The disease often occurs between age group of 20-40. MS is mainly divided into four types. They are relapsing-remitting MS, progressive-relapsing MS, secondary-progressive MS and primary-progressive MS. Relapsing-remitting MS is the most common form of the disease. It accounts about 85% of the total MS cases. Secondary-progressive is associated with the initial period of relapsing-remitting disease. Approximately, 50% of people suffering with relapsing remitting MS would develop this form of the disease. Progressive-relapsing MS is rare and about 5% of the total MS cases. Primary-progressive MS accounts 10% of the total MS cases.

In terms of geographic, North America dominates the global MS drugs market. The U.S. represents the largest market for MS drugs followed by Canada in North America. In Europe, France, Germany, Italy, Spain and the U.K. holds major share of MS drugs market. However, Asia is expected to show high growth rates in the next five years in global MS drugs market. This is due to many companies constructing their manufacturing and research facilities in the region. Developing regions have advantage over the developed regions due to low wages, availability of a large talent pool, less stringent environment and health and safety regulations. Japan, China and India are expected to be the fastest growing MS drugs markets in Asia.

In 2018, the global Multiple Sclerosis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Multiple Sclerosis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis Drugs development in United States, Europe and China.

The key players covered in this study

- GlaxoSmithKline

- Novartis

- Merck

- Sanofi

- Pfizer

- Bayer

- Teva Pharmaceutical

- Abbvie

- Biogen Idec

- AB Science

- Opexa

Market segment by Type, the product can be split into

- Oral Drugs

- Parenteral Drugs

Market segment by Application, split into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Multiple Sclerosis Drugs status, future forecast, growth opportunity, key market and key players.

- To present the Multiple Sclerosis Drugs development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Multiple Sclerosis Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Multiple Sclerosis Drugs Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Sclerosis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Drugs
1.4.3 Parenteral Drugs
1.5 Market by Application
1.5.1 Global Multiple Sclerosis Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Multiple Sclerosis Drugs Market Size
2.2 Multiple Sclerosis Drugs Growth Trends by Regions
2.2.1 Multiple Sclerosis Drugs Market Size by Regions (2014-2025)
2.2.2 Multiple Sclerosis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Multiple Sclerosis Drugs Market Size by Manufacturers
3.1.1 Global Multiple Sclerosis Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Multiple Sclerosis Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multiple Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Sclerosis Drugs Key Players Head office and Area Served
3.3 Key Players Multiple Sclerosis Drugs Product/Solution/Service
3.4 Date of Enter into Multiple Sclerosis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Multiple Sclerosis Drugs Market Size by Type (2014-2019)
4.2 Global Multiple Sclerosis Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Multiple Sclerosis Drugs Market Size (2014-2019)
5.2 Multiple Sclerosis Drugs Key Players in United States
5.3 United States Multiple Sclerosis Drugs Market Size by Type
5.4 United States Multiple Sclerosis Drugs Market Size by Application
6 Europe
6.1 Europe Multiple Sclerosis Drugs Market Size (2014-2019)
6.2 Multiple Sclerosis Drugs Key Players in Europe
6.3 Europe Multiple Sclerosis Drugs Market Size by Type
6.4 Europe Multiple Sclerosis Drugs Market Size by Application
7 China
7.1 China Multiple Sclerosis Drugs Market Size (2014-2019)
7.2 Multiple Sclerosis Drugs Key Players in China
7.3 China Multiple Sclerosis Drugs Market Size by Type
7.4 China Multiple Sclerosis Drugs Market Size by Application
8 Japan
8.1 Japan Multiple Sclerosis Drugs Market Size (2014-2019)
8.2 Multiple Sclerosis Drugs Key Players in Japan
8.3 Japan Multiple Sclerosis Drugs Market Size by Type
8.4 Japan Multiple Sclerosis Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Multiple Sclerosis Drugs Market Size (2014-2019)
9.2 Multiple Sclerosis Drugs Key Players in Southeast Asia
9.3 Southeast Asia Multiple Sclerosis Drugs Market Size by Type
9.4 Southeast Asia Multiple Sclerosis Drugs Market Size by Application
10 India
10.1 India Multiple Sclerosis Drugs Market Size (2014-2019)
10.2 Multiple Sclerosis Drugs Key Players in India
10.3 India Multiple Sclerosis Drugs Market Size by Type
10.4 India Multiple Sclerosis Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Multiple Sclerosis Drugs Market Size (2014-2019)
11.2 Multiple Sclerosis Drugs Key Players in Central & South America
11.3 Central & South America Multiple Sclerosis Drugs Market Size by Type
11.4 Central & South America Multiple Sclerosis Drugs Market Size by Application
12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Sclerosis Drugs Introduction
12.1.4 GlaxoSmithKline Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Sclerosis Drugs Introduction
12.2.4 Novartis Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Sclerosis Drugs Introduction
12.3.4 Merck Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Sclerosis Drugs Introduction
12.4.4 Sanofi Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Sclerosis Drugs Introduction
12.5.4 Pfizer Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Multiple Sclerosis Drugs Introduction
12.6.4 Bayer Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Multiple Sclerosis Drugs Introduction
12.7.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development
12.8 Abbvie
12.8.1 Abbvie Company Details
12.8.2 Company Description and Business Overview
12.8.3 Multiple Sclerosis Drugs Introduction
12.8.4 Abbvie Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.8.5 Abbvie Recent Development
12.9 Biogen Idec
12.9.1 Biogen Idec Company Details
12.9.2 Company Description and Business Overview
12.9.3 Multiple Sclerosis Drugs Introduction
12.9.4 Biogen Idec Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.9.5 Biogen Idec Recent Development
12.10 AB Science
12.10.1 AB Science Company Details
12.10.2 Company Description and Business Overview
12.10.3 Multiple Sclerosis Drugs Introduction
12.10.4 AB Science Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.10.5 AB Science Recent Development
12.11 Opexa
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Multiple Sclerosis Drugs Key Market Segments
Table Key Players Multiple Sclerosis Drugs Covered
Table Global Multiple Sclerosis Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Drugs Market Size Market Share by Type 2014-2025
Figure Oral Drugs Figures
Table Key Players of Oral Drugs
Figure Parenteral Drugs Figures
Table Key Players of Parenteral Drugs
Table Global Multiple Sclerosis Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Multiple Sclerosis Drugs Report Years Considered
Table Global Multiple Sclerosis Drugs Market Size 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multiple Sclerosis Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Multiple Sclerosis Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Multiple Sclerosis Drugs Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Drugs Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Multiple Sclerosis Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Multiple Sclerosis Drugs Market Share by Manufacturers (2014-2019)
Figure Global Multiple Sclerosis Drugs Market Share by Manufacturers in 2018
Table Global Multiple Sclerosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multiple Sclerosis Drugs Product/Solution/Service
Table Date of Enter into Multiple Sclerosis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Multiple Sclerosis Drugs Market Size Share by Type (2014-2019)
Figure Global Multiple Sclerosis Drugs Market Size Market Share by Type (2014-2019)
Table Global Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Multiple Sclerosis Drugs Market Size Share by Application (2014-2019)
Figure Global Multiple Sclerosis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Multiple Sclerosis Drugs Revenue Market Share by Application in 2018
Figure United States Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table United States Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table United States Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure Europe Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table Europe Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table Europe Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure China Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table China Multiple Sclerosis Drugs Market Size by Type (2014-20189) (Million US$)
Table China Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table China Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table China Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure Japan Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table Japan Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table Japan Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table Southeast Asia Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table Southeast Asia Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure India Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table India Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table India Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table India Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table India Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure Central & South America Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table Central & South America Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table Central & South America Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Multiple Sclerosis Drugs Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Bayer Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Abbvie Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Biogen Idec Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Biogen Idec Recent Development
Table AB Science Company Details
Table AB Science Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure AB Science Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table AB Science Recent Development
Table Opexa Company Details
Table Global Multiple Sclerosis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Multiple Sclerosis Drugs Market Size Share by Regions (2019-2025)
Figure Global Multiple Sclerosis Drugs Market Size Share by Regions in 2025
Figure United States Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Multiple Sclerosis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Drugs Market Size by Product (2019-2025)
Figure Global Multiple Sclerosis Drugs Market Size by Product in 2025
Table Global Multiple Sclerosis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Drugs Market Size by Application (2019-2025)
Figure Global Multiple Sclerosis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Fingolimod Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Fingolimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Multiple Sclerosis Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Multiple Sclerosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......
  • Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Multiple Sclerosis market: According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years. Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurode......
  • Fingolimod - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 77
    The global Fingolimod market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fingolimod in various end use industries. The expanding demands from the Medical Field, Science Research Field and Other Fields,, are propelling Fingolimod market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inj......
  • Global Fingolimod Market Research Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Fingolimod Professional Survey Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Multiple Sclerosis Drugs, with both qu......
  • Global Multiple Sclerosis Drugs Market Research Report 2023
    Published: 25-Oct-2023        Price: US 2900 Onwards        Pages: 87
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Sclerosis Drugs market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Biogen - Sanofi - Novartis - Teva - Merck KGaA - Bayer - ACORDA - Mallinckrodt Segment by Type - Injectable......
  • Global Multiple Sclerosis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 13-Jun-2023        Price: US 3260 Onwards        Pages: 122
    Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. The Multiple Sclerosis Drugs market revenue was 15099.44 Million USD in 2022, and will reach 23584.78 Million USD in 2028, with a CAGR of 7.72% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclero......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs